Jill Makin
Jill Makin is Chief Scientific Officer, Toughlight Limited.
ArticleAntibiotics in biopharmaceutical production
As per the WHO, antimicrobial resistance (AMR) is a global health threat and a complex problem that requires a united multisectoral approach. In the interest of patients and environmental safety, regulators around the globe are discouraging the use of antibiotics in all areas of their utilisation ie, not only at ...
